A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats

Research Communications in Molecular Pathology and Pharmacology

Volumn 104, Issue 3, 1999, Pages 307-319

  Horiuchi, Hideki ^a   Ota, Mikio ^a   Kobayashi, Mitsuru ^a   Kaneko, Hideshi ^a   Kasahara, Yoshinori ^a   Nishimura, Shin Ichi ^a   Kondo, Shiro ^a   Komoriya, Keiji ^a  

^a TEIJIN LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLANTOIN; ALLOPURINOL; FEBUXOSTAT; UNCLASSIFIED DRUG; URIC ACID; XANTHINE; XANTHINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; HYPOURICEMIA; MALE; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; PURINE METABOLISM; RAT; URIC ACID URINE LEVEL; URINARY EXCRETION;

ALLANTOIN; ALLOPURINOL; ANIMALS; ENZYME INHIBITORS; KIDNEY CALCULI; MALE; RATS; RATS, INBRED STRAINS; THIAZOLES; URIC ACID; XANTHINE; XANTHINE OXIDASE;

EID: 0033511044     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Dan, T., Yoneya, T., Onoma, M., Onuma, E. and Ozawa, K. (1994) Hypouricemic and uricosuric actions of AA-193 in a hyperuricemic rat model. Metabolism 43: 123-128.
2. Hasegawa, M. (1998) A facile one-pot synthesis of 4-alkoxy-1,3-benzenecarbonitrile. Heterocycles 47: 857-864.
3. Higashino, K. and Yamamoto, T. (1987) Xanthinuria. Nippon Rinsho 45: 810-811.
4. Hitchings, G.H. (1966) Effects of allopurinol in relation to purine biosynthesis. Ann. Rheum. Dis. 25:601-607.
5. Isa, M., Hayashi, G. and Kowa, Y. (1968) Effects of xanthine oxidase inhibitor, 4-hydroxypyrazolo-(3, 4-d)-pyrimidine (zyloric) on nucleic acid metabolism and its pharmacological actions. 1. Folia Pharmacol. Jpn. 64: 108-122.
6. Komoriya, K., Osada, Y., Hasegawa, M., Horiuchi, H., Kondo, S., Couch, R.C. and Griffin, T.B. (1993) Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees. Eur. J. Pharmacol. 250: 455-460.
7. Landgrebe, A.R., Nyhan, W.L. and Coleman, M. (1975) Urinary-tract stones resulting from the excretion of oxypurinol. N. Engl. J. Med. 292: 626-627.
8. Ogawa, A., Watnabe, K. and Minejima, N. (1985) Renal xanthine stone in Lesch-Nyhan syndrome treated with allopurinol. Urology 26: 56-58.
9. Osada, Y., Tsuchimoto, M., Fukushima, H., Takahasi, K., Kondo, S., Hasegawa, M. and Komoriya, K. (1993) Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents. Eur. J. Pharmacol. 241: 183-188.
10. Stole, R.M., Smith, L.H., Dubb, J.W., Moyer, T.P., Alexander, F. and Roth, J.L. (1980) Oxypurinol nephrolithiasis in regional enteritis secondary to allopurinol therapy. Ann. Inten. Med. 92: 384-385.